ACELYRIN, INC.’s Post

View organization page for ACELYRIN, INC., graphic

6,032 followers

The unknown aspects of participating in clinical trials can be daunting for any patient, especially those with lesser-known conditions like #HidradenitisSuppurativa (HS). HS is a debilitating, chronic, and complex inflammatory illness, often described as an immune-mediated inflammatory disease or follicular occlusion disorder. This #HSAwarenessWeek, HS advocate and founder of HS Connect Brindley Brooks speaks to the importance of transparency in clinical trial processes.

To view or add a comment, sign in

Explore topics